Sabra Health Care REIT, Inc. (SBRA) Income Statement

The shift from high single-digit growth through 2025 to 20% to 31% growth in the most recent quarters appears to reflect a combination of acquisitions, SHOP occupancy recovery, and rent escalators. Because the source data does not break out the contribution of each driver, the relative weight of organic versus acquisition-led growth cannot be confirmed from these figures. Investors should monitor whether growth holds once acquisition timing effects roll off.

This pattern is consistent with a higher share of SHOP revenue, which carries operating expense intensity closer to a hospitality model than to triple-net leasing. The margin decline may also reflect labor cost pressure, though the data does not isolate labor expense directly. Investors should watch whether margins stabilize as occupancy gains flow through to the managed portfolio.

The swing in FFO per share appears driven by non-recurring items and timing of transactions rather than a steady operating trend, as the 2026Q2 trough and 2025Q2 peak sit far from the intervening averages. The available data does not reveal the composition of these swings, so conclusions about sustainable run-rate FFO should be treated cautiously. Dividend coverage deserves close review against AFFO once that series is fully populated.

For a healthcare REIT, GAAP net income is structurally depressed by real estate depreciation and can also be affected by joint venture accounting and impairments. The gap between NOI of $146.6M and net income of $28.6M in the latest quarter illustrates how much of property-level profit is absorbed below the line. Analysts should anchor valuation to FFO and AFFO rather than reported EPS.